As expected this protocol also yielded CD46 knockout cells with superior efficiency (S2D Fig) indicating that EBV infection ensures the cells’ in vitro survival, only, but does not contribute to the efficiency of gene editing using the CRISPR-Cas9 technology. Here, CD46 is linked to Epstein-Barr virus infection.